Drugs@FDA: search confirms no approved 5-Amino-1MQ product as of June 2026
Protocol 3: Severe mood and anxiety symptoms Goal: Stabilize mood, reduce anxiety, improve mental health Mood-focused stack: Selank: 300-600mcg intranasal, 2x daily CJC-1295 + Ipamorelin: 200mcg each before bed (sleep critical for mood) BPC-157: 250mcg twice daily (gut-brain axis) Semax: 300mcg morning (brain fog, motivation) Why this works: Selank: Direct anxiolytic and mood stabilizing effects GH peptides: Improve sleep better mood regulation BPC-157: Heal gut (gut-brain connection critical) Semax: Mental clarity and focus Benefits: Reduced anxiety and panic More stable mood Less irritability and rage Better stress resilience Improved cognitive function Timeline: Week 1: Initial calming effects (Selank) Week 2-4: Significant mood improvement Month 2-3: Sleep and energy improving (GH peptides) Month 3+: Comprehensive mental health enhancement Cost: $350-500/month Protocol 4: Energy and vitality focus Goal: Combat crushing fatigue and restore energy Energy stack: CJC-1295 + Ipamorelin: 250mcg each before bed Semax: 300-600mcg intranasal morning BPC-157: 250mcg twice daily NAD+: Weekly or as needed Benefits: Restored physical energy Enhanced mental clarity Better exercise recovery Improved stamina Sustained vitality throughout day Timeline: Week 1-2: Better sleep slight energy increase Week 3-4: Noticeable daily energy improvement Week 6-8: Significant vitality restoration Month 3+: Sustained high energy See our best peptide for peptide selection guide
The GLOW Protocol is a peptide therapy regimen that combines three regenerative peptides commonly used to support healing, recovery, and skin health: GHK-Cu GHK-Cu , often called a copper peptide, is known for its role in supporting collagen production, skin rejuvenation, and tissue repair
found that general control of amino acid synthesis 5 like 1 (GCN5L1) in mitochondria of liver cancer cells can promote the acetylation and inactivation of GLS1 and GLS2 isomers, thus inhibiting mTORC1 activation and cell proliferation
J Clin Med (2022) 11:2551
(Springer International Publishing AG, Cham, Switzerland), 309329
